Semantic Scholar uses AI to extract papers important to this topic.
The purpose of this study was to perform self-healing encapsulation of ONO-1301, a long-acting prostacyclin agonist, into poly… Expand BACKGROUND
ONO-1301, a novel sustained-release prostacyclin agonist, has an anti-fibrotic effect on the lungs, heart, and kidneys… Expand The purpose of this study was to evaluate the angiogenic potency of ONO-1301, a novel prostacyclin agonist, using a murine sponge… Expand Tubulointerstitial injuries are crucial histological alterations that predict the deterioration of renal function in chronic… Expand Objectives ONO‐1301 was developed as a novel long‐acting prostacyclin agonist with thromboxane synthase inhibitory activity. In… Expand Impairment of cardiac function in cardiomyopathy has been postulated to be related to decreased blood flow and increased collagen… Expand It has been shown previously that administration of angiogenic growth factors as genes or proteins can augment collateral growth… Expand The balance between prostacyclin and thromboxane A2 (TXA2) plays an important role in pulmonary homeostasis. However, little… Expand In the present study, we examined the effects of prostaglandin E1 (PGE1) on the expression of intercellular adhesion molecule… Expand The antinephritic effects of ONO-1301 ([7,8-dihydro-5-[(E)-[[a-(3-pyridyl)benzylidene]-aminooxy]ethyl]-1 -naphtyloxy]acetic acid… Expand